Related Experiment Videos
Hypoglycaemic activity of alpha, alpha trehalose-6-phosphate
African Journal of Medicine and Medical Sciences
|September 25, 1999
Summary
Alpha-alpha-trehalose-6-phosphate demonstrates significant anti-diabetic effects by lowering blood glucose in rabbits and reducing toxicity in diabetic rats. Its mechanism involves inhibiting trehalase and acting as a glucose analogue.
Area of Science:
- Biochemistry
- Pharmacology
- Endocrinology
Background:
- Diabetes mellitus is a metabolic disorder characterized by hyperglycemia.
- Alpha-alpha-trehalose-6-phosphate is a synthesized compound with potential therapeutic applications.
- Understanding novel hypoglycemic agents is crucial for diabetes management.
Purpose of the Study:
- To evaluate the hypoglycemic and anti-diabetic activity of synthesized alpha-alpha-trehalose-6-phosphate.
- To investigate the mechanism of action of alpha-alpha-trehalose-6-phosphate.
- To assess its efficacy in animal models of diabetes.
Main Methods:
- Screening for hypoglycemic activity in fasted rabbits.
- Assessing anti-diabetic effects in alloxan-induced diabetic rats.
- Enzyme inhibition assays for trehalase activity.
- Measurement of superoxide dismutase activity in pancreatic beta-cells.
Main Results:
- Alpha-alpha-trehalose-6-phosphate exhibited potent hypoglycemic activity in fasted rabbits.
- The compound demonstrated significant attenuation of diabetic toxicity in alloxan-induced diabetic rats.
- Inhibition of trehalase and increased superoxide dismutase activity were observed.
- Its action as a glucose analogue influences carbohydrate intermediate metabolism.
Conclusions:
- Alpha-alpha-trehalose-6-phosphate possesses potent anti-hyperglycemic and anti-diabetic properties.
- The compound's mechanism of action is linked to trehalase inhibition and antioxidant effects.
- Further research into alpha-alpha-trehalose-6-phosphate as a diabetes therapeutic is warranted.